Wird geladen...
CAR therapy: the CD19 paradigm
Twenty-five years after its inception, the genetic engineering of T cells is now a therapeutic modality pursued at an increasing number of medical centers. This immunotherapeutic strategy is predicated on gene transfer technology to instruct T lymphocytes to recognize and reject tumor cells. Chimeri...
Gespeichert in:
| Veröffentlicht in: | J Clin Invest |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Clinical Investigation
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4588281/ https://ncbi.nlm.nih.gov/pubmed/26325036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI80010 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|